Sanofi’s Lih-Ling Lin joins PharmaEssentia as CSO

Taiwan-based hematology and oncology company PharmaEssentia Corp. (TPEx:6446) hired Lih-Ling Lin as CSO. Lin was most recently head of checkpoint immunology at Sanofi (Euronext:SAN; NASDAQ:SNY), before which she held various R&D roles at Pfizer Inc. (NYSE:PFE) over 21 years.

ProfoundBio Co. Ltd. hired Naomi Hunder as CMO. A medical oncologist, Hunder joins from Silverback Therapeutics Inc. (NASDAQ:SBTX), where she was CMO. Profound also announced that FDA had cleared its IND for PRO1184, a FOLR1-directed antibody-drug conjugate, for study in various solid tumors...